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Development of antiproliferative nanohybrid compound with controlled release 
property using ellagic acid as the active agent. 
 
ABSTRACT 
An ellagic acid (EA)–zinc layered hydroxide (ZLH) nanohybrid (EAN) was synthesized 
under a nonaqueous environment using EA and zinc oxide (ZnO) as the precursors. Powder 
X-ray diffraction showed that the basal spacing of the nanohybrid was 10.4 Å, resulting in the 
spatial orientation of EA molecules between the interlayers of 22.5° from z-axis with two 
negative charges at 8,8′ position of the molecules pointed toward the ZLH interlayers. FTIR 
study showed that the intercalated EA spectral feature is generally similar to that of EA, but 
with bands slightly shifted. This indicates that some chemical bonding of EA presence 
between the nanohybrid interlayers was slightly changed, due to the formation of host–guest 
interaction. The nanohybrid is of mesopores type with 58.8% drug loading and enhanced 
thermal stability. The release of the drug active, EA from the nanohybrid was found to be 
sustained and therefore has good potential to be used as a drug controlled-release formulation. 
In vitro bioassay study showed that the EAN has a mild effect on the hepatocytes cells, 
similar to its counterpart, free EA. 
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